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Metabolically generated acid is the major physiological
stimulus for increasing proximal tubule citrate reabsorption,
which leads to a decrease in citrate excretion. The activity
of the Na-citrate cotransporter, NaDC-1, is increased in vivo
by acid ingestion and in vitro by an acidic pH medium.
In opossum kidney cells the acid stimulatory effect and the
ability of endothelin-1 (ET-1) to stimulate NaDC-1 activity are
both blocked by the endothelin B (ETB) receptor antagonist,
BQ788. Acid feeding had no effect on brush border
membrane NaDC-1 activity in mice in which ETB receptor
expression was knocked out, whereas a stimulatory effect
was found in wild-type mice. Using ETA/ETB chimeric and
ETB C-terminal tail truncated constructs, ET-1 stimulation of
NaDC-1 required a receptor C-terminal tail from either ETA or
ETB. The ET-1 effect was greatest when either the ETB
transmembrane domain and C-terminal tail were present or
the ETB C-terminal tail was linked to the ETA transmembrane
domain. This effect was smaller when the ETB
transmembrane domain was linked to the ETA C-terminal tail.
Thus, the acid-activated pathway mediating stimulation of
NaDC-1 activity requires a functional ETB receptor in vivo and
in vitro, as does acid stimulation of NHE3 activity. Since
increased NaDC-1 and NHE3 activities constitute part of the
proximal tubule adaptation to an acid load, these studies
indicate that there are similarities in the signaling pathway
mediating these responses.
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Diet-associated acid loads are the major determinant of
urinary citrate excretion. Urinary citrate is an important
inhibitor of nephrolithiasis and nephrocalcinosis, as it
complexes urinary calcium, preventing the calcium from
forming insoluble complexes with oxalate and other anions.
Hypocitraturia is present in about half of recurrent stone
forming patients and its presence correlates highly with the
dietary acid load.1,2 Chronic metabolic acidosis, chronic
potassium deficiency (a model of low intracellular pH),
and diets high in animal protein reduce urinary citrate
excretion and significantly increase the risk for kidney stone
formation.2–10 Understanding the mechanism by which
dietary acid reduces citrate excretion is essential to identify-
ing mechanisms by which the risk for kidney stone formation
can be reduced.
Citrate is freely filtered at the glomerulus and the
magnitude of citrate excretion is determined solely by its
rate of reabsorption and metabolism in the kidney proximal
tubule. Citrate is transported across both the apical and
basolateral membranes by Na-coupled, electrogenic trans-
porters. The Na-dependent dicarboxylate transporter
isoform-1 (NaDC-1) mediates citrate uptake across the
apical membrane, and is stimulated by acidic intracellular
pH and dietary acid loads.11–16 Reabsorbed citrate is
metabolized in the proximal tubule. NaDC-3 mediates citrate
uptake across the basolateral membrane.14,16,17 However,
unlike transport across the apical membrane, citrate trans-
port across the basolateral membrane is inhibited by acidic
pH. The rate and magnitude of reabsorption across the apical
membrane is the major determinant of citrate excretion, and,
thus, the risk for kidney stone formation.
To elucidate the acid-activated pathway that mediates acid
stimulation of NaDC-1 activity we used an opossum kidney
cell line (OKP) that possesses many characteristics of the
renal proximal tubule.18 The OKP Na-dependent dicarbox-
ylate cotransporter (oNaDC-1) expressed in Xenopus oocytes
shows functional characteristics similar to those of the rat,
rabbit, and human apical membrane NaDC-1 protein.19
These studies conducted in both OKP cells and mice
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demonstrate that media acidification or acid feeding,
respectively, requires a functional endothelin B (ETB)
receptor to stimulate NaDC-1 activity.
RESULTS
OKP cells transfected with oNaDC-1 shows acid regulation of
transporter activity
Native OKP cells show minimal [14C]-citrate uptake in the
absence or presence of Na, in spite of the fact that they
express oNaDC-1 mRNA. Therefore, we overexpressed
oNaDC-1 in all studies. OKP cells transfected with the
oNaDC-1 construct (green fluorescent protein (GFP)-
oNaDC-1) show Na-dependent [14C]-citrate uptake at rates
that are significantly higher than observed in cells transfected
with GFP only (Figure 1). Media acidification has no effect
on [14C]-citrate uptake in the absence of Na, but significantly
increases the rate of citrate uptake in the presence of Na
(Figure 1).
oNaDC-1 is stimulated by media acidification in a dose- and
time-dependent manner
OKP cells transfected with oNaDC-1 and exposed to media
of pH 7.4, 7.3, 7.2, 7.0, or 6.8 show pH-sensitive [14C]-citrate
uptake, with the highest rate of uptake at pH 6.8 (Figure 2a).
Activation with pH 6.8 media begins within 2 h and persists
for 24 h (Figure 2b).
oNaDC-1 is stimulated by ET-1 in a dose- and time-dependent
manner in the presence of the ETB receptor
OKP cells transfected with oNaDC-1 and ETB, and then
exposed to vehicle (acetic acid) or ET-1 (1010 to 107mol/l)
show dose-dependent stimulation of [14C]-citrate uptake
with a significant effect observed at ET-1 concentrations of
108mol/l or higher (Figure 3a). Significant activation with
108mol/l ET-1 begins within 15min and lasts for 4 h
(Figure 3b).
oNaDC-1 is stimulated by acid and ET-1 signaling through the
ETB, but not the ETA receptor
We have previously shown that acid stimulation of another
proximal tubule brush border membrane transporter, NHE3,
is mediated by autocrine activation of the ETB receptor
by ET-1.20 To determine the receptor requirement for
ET-1 stimulation of oNaDC-1 activity, studies were con-
ducted in the presence or absence of transfected ETB receptor
and in the presence or absence of a specific ETB receptor
blocker, BQ788.21 As shown in Figure 4a, cells transfected
with the ETB receptor show greater citrate uptake when
GFP only
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Figure 1 |Opossum kidney cell line (OKP) cells transfected
with OKP Na-dependent dicarboxylate cotransporter-1
(oNaDC-1) show acid-regulated Na-dependent citrate uptake.
OKP cells were exposed to control (pH 7.4) or acid (pH 6.8)
media 6 h. oNaDC-1 activity was assayed using [14C]-citrate
uptake and expressed as pmol of citrate/mg protein/5min.
*Po0.05 versus minus Naþ ; #Po0.05 versus plus Naþ control.
n¼ 3 for green fluorescent protein (GFP) only; n¼ 12 for GFP-
oNaDC-1 Con (control) and acid groups.
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Figure 2 |Opossum kidney cell line (OKP) cells transfected
with OKP Na-dependent dicarboxylate cotransporter-1
(oNaDC-1) show pH- and time-dependent increases in citrate
uptake after media acidification. (a) pH is noted on the x-axis;
y-axis: citrate uptake expressed as pmol/mg protein/5min.
*Po0.05 versus pH 7.4. n¼ 9 for each pH. (b) x-axis: length of
exposure to acidic media; y-axis: acid:control ratio at each time
point. *Po0.05 versus no percentage change in the ratio (100).
n¼ 9 for all time points except 12 h, where n¼ 8. oNaDC-1 activity
was assayed using [14C]-citrate uptake.
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exposed to 108mol/l ET-1. The ETB receptor blocker,
BQ788, blocks entirely ET-1 stimulation of [14C]-citrate
uptake in cells transfected with vector alone (native ETB
receptor only) or the ETB receptor (native and exogenous
ETB receptor).
Similarly, the effect of media acidification on [14C]-citrate
uptake is greater in cells transfected with the ETB receptor
(native and exogenous ETB receptor) compared with cells
transfected with vector alone (native ETB receptor only), and
BQ788 blocks the effect of media acidification in both
situations (Figure 4b). Thus, both acid and ET-1 stimulation
of oNaDC-1 activity requires the ETB receptor.
In contrast, as shown in Figure 5 (right set of bars), when
cells are transfected with the ETA receptor, 10
8mol/l ET-1
decreases, rather than increases [14C]-citrate uptake. In
addition, comparing the left set of bars (cells transfected
with NaDC-1 only, native ETB only) with the right set of bars
(cells transfected with NaDC-1þ ETA, native ETB present),
overexpressing the ETA receptor inhibits baseline activity. A
possible explanation for this observation is that in the
absence of ligand (right set of bars, vehicle (first bar) and
vehicleþBQ788 (third bar)) the ‘empty’ ETA receptor
inhibits baseline oNaDC-1 activity (compare bars 1 and 3
in the right set to bars 1 and 3 in the left set), and ligand (ET-
1) binding to the overexpressed ETA receptor (right set of
bars, bar 2) causes an ET-1 induced inhibition of oNaDC-1
activity, whereas ligand binding to the ETB receptor in the
absence of ETA receptor expression (left set of bars, bar 2)
stimulates oNaDC-1 activity. Thus, in the presence of
transfected ETA and endogenous ETB receptor (right set of
bars), the effect of the ETA receptor predominates, and
baseline and ET-1 regulated oNaDC-1 activities decrease.
This hypothesis predicts that in ETA-transfected cells exposed
to BQ788 (no functional ETB receptor present), ET-1 should
again inhibit oNaDC-1 activity. As shown in Figure 5 (right
set of bars, fourth bar), oNaDC-1 activity is lower than
baseline (compared with the first bar in the set), but did not
achieve statistical significance.
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Figure 3 |Opossum kidney cell line (OKP) cells transfected
with OKP Na-dependent dicarboxylate cotransporter-1
(oNaDC-1) and endothelin B (ET)B show both dose- and
time-dependent ET-1 stimulation of oNaDC-1 activity.
(a) Dose-dependent study. oNaDC-1 activity was assayed as [14C]-
citrate uptake after 35min exposure to the indicated ET-1
concentrations. *Po0.05 versus vehicle. n¼ 9 for all ET-1
concentrations. (b) Time-dependent study after exposure to
108mol/l ET-1. *Po0.05 versus vehicle; #P¼ 0.09 versus vehicle.
n¼ 12 for studies at 5, 10, 15, and 25min; n¼ 9 for studies at
35min and 1 h; n¼ 6 for studies at 4 and 8 h.
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Figure 4 | Endothelin-1 (ET-1) stimulation of opossum kidney
cell line Na-dependent dicarboxylate cotransporter-1
(oNaDC)-1 activity is dependent on the ETB receptor. Cells
were co-transfected with oNaDC-1 alone (left set of bars) or
oNaDC-1þ ETB (right set of bars). oNaDC-1 activity was assayed
as [14C]-citrate uptake and reported as pmol/mg protein/5min.
(a) Cells were exposed to vehicle or 108mol/m ET-1 35min.
n¼ 8 for vehicle and n¼ 9 for BQ788 studies. *Po0.01 versus
vehicle. (b) Cells were exposed to media of pH 7.4 (con) or 6.8
(acid) 6 h. n¼ 8 for all studies. *Po0.05 versus pH 7.4; #P¼ 0.06
versus pH 7.4.
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Location of oNaDC-1 expression associated with acid and
ET-1 stimulation of oNaDC-1 activity
To determine whether exposure to media acidification
(Figure 6a) or ET-1 (Figure 6b) affects the intracellular
location of transfected oNaDC-1, confocal microscopy
studies were carried out making use of the GFP tag on
oNaDC-1. In control-transfected cells, although the majority
of GFP-oNaDC-1 expression is located in the cytoplasm,
there is expression on the apical side of the cell, but no
detectable expression on the basolateral side. The apical
expression likely accounts for the increased citrate uptake in
transfected control cells compared with untransfected cells
(Figure 1). After exposure to either acid pH or ET-1, GFP-
oNaDC-1 expression moves from a predominantly cytoplas-
mic location to the apical side of the cell, still with no
detectable expression on the basolateral side. Thus, although
post-translational modification of apically expressed NaDC-1
cannot be ruled out, the parallel increase in expression on the
apical side of the cell and NaDC-1 activity strongly suggests
that trafficking from a cytoplasmic pool to the apical
membrane contributes significantly to the increase in
NaDC-1 activity.
Acid stimulation of oNaDC-1 activity is mediated by the ETB
receptor in vivo
To confirm that ET-1/ETB signaling is required for acid
stimulation of NaDC-1 activity in vivo, studies were carried
out in wild-type (ETB
þ /þ ) and ETB receptor-deficient
(ETB
/) mice. The ETB
/ mice were created by removing
exon 3 of the coding sequence and replacing it with a neo-
cassette.22 The phenotype, which is neonatally lethal, was
rescued by expression of a dopamine b-hydroxylase promoter/
ETB receptor transgene.
22–24 In the rescued mice, confirma-
tion that the ETB receptor was not expressed in the kidney
was obtained from polymerase chain reaction studies carried
out using a forward primer from exon 1 and a reverse primer
from exon 3. The results showed a polymerase chain reaction
product of B687 bp in renal cortex harvested from ETB
þ /þ
animals, but no polymerase chain reaction product in cortex
harvested from ETB
/ animals (data not shown).
Mice had ad lib access to either regular drinking water
(control) or drinking water containing 0.3mol/l NH4Cl
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Figure 5 | Endothelin-1 (ET-1) does not stimulate opossum
kidney cell line Na-dependent dicarboxylate cotransporter-1
(oNaDC-1) activity in opossum kidney cells transfected with
ETA. Cells were cotransfected with oNaDC-1 or oNaDC-1þ ETA.
oNaDC-1 activity was assayed as [14C]-citrate uptake. *Po0.001
versus vehicle; **Po0.01 versus vehicle n¼ 9 for all studies.
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Figure 6 |Apical membrane opossum kidney cell line Na-dependent dicarboxylate cotransporter-1 expression increases after either
media acidification or exposure to 108mol/l endothelin-1 (ET-1). Cells were prepared for confocal microscopy as described in the
Methods section. (a) Green fluorescent protein (GFP) expression comparing exposure to control (pH 7.4) and acid (pH 6.8) media 6 h.
(b) GFP expression comparing exposure to vehicle and 108mol/l ET-1 35min. Typical pictures for both panels.
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(acid). As shown in Table 1, after 7 days of acid feeding,
blood pH and [HCO3] are significantly decreased in both
acid fed groups compared with their respective control
groups, with blood [HCO3] decreased to a similar extent in
the two groups. In addition, there are no differences in
arterial blood gases between the ETB
þ /þ and ETB
/ mice. As
shown in Figure 7, Na-dependent [14C]-citrate uptake,
assayed in brush border membrane vesicles (BBMVs)
harvested from renal cortex, is significantly increased by acid
feeding to ETB
þ /þ mice, but acid feeding is without effect on
Na-dependent [14C]-citrate uptake in the ETB
/ mice.
Although baseline (control) NaDC-1 activity seemed
increased in the ETB
/ mice, it is not significantly different
than baseline NaDC-1 activity in the ETB
þ /þ mice. Thus, in
both in vitro and in vivo models of an acid load the presence
of a functional ETB receptor is required for acid stimulation
of NaDC-1 activity.
A C-terminal tail is required for ET-1 stimulation of oNaDC-1
activity
To elucidate the region(s) of the ETB receptor required
for ET-1 stimulation of oNaDC-1 activity, studies were
conducted using ETA/ETB chimeric and ETB C-terminal
deletion constructs. ETA and ETB receptors exhibit 55%
overall amino acid homology.25,26 Within the receptor
domains, the C-terminal region has the least amount of
homology and the transmembrane (TM) domains the most
homology.
As shown in previous studies, OKP cells transfected with
the wild-type ETB receptor showed ET-1-induced stimulation
of NaDC-1 activity (Figure 8, first bar), whereas cells
transfected with the ETA receptor showed no stimulation
(Figure 8, fourth bar). Removing the C-terminal tail from the
ETB receptor (Figure 8, ETB no tail, second bar) prevents
ET-1 stimulation of oNaDC-1, showing that a C-terminal tail
is required. Replacing the ETB C-terminal tail with the ETA
C-terminal tail (Figure 8, ETB TM/ETA tail, third bar)
significantly reduces the ET-1 effect (Figure 8, compare first
and third bars), but a significant effect is still observed.
Replacing the ETA C-terminal tail with the ETB C-terminal
tail (Figure 8, ETA TM/ETB tail, fifth bar) restores ET-1
stimulation of oNaDC-1 activity to a magnitude not different
than that observed with the wild-type ETB receptor (Figure 8,
compare first and fifth bars).
There is no difference in the minimal ET-1 effect when
comparing cells transfected with ETB no tail (second bar),
ETB TM/ETA tail (third bar), and wild-type ETA (fourth bar)
(all comparisons non-significant), and the minimal
ET-1 effect observed in these three groups is significantly
smaller than that observed when cells are transfected with
wild-type ETB receptor (compare first bar with second–fourth
bars). Taken together, these studies show that (1) the ETB
receptor requires a C-terminal tail for ET-1 stimulation of
oNaDC-1 activity, (2) the ET-1 effect is greatest when both
the ETB TM and C-terminal regions of the receptor are
present or when the ETB C-terminal domain is linked to the
ETA TM domains, (3) ET-1 does not increase oNaDC-1
activity in the presence of the wild-type ETA receptor. Thus,
maximal ET-1 stimulation requires the presence of the ETB
C-terminal tail.
ETB C-terminal region required for ET-1 stimulation of
oNaDC-1 activity
On the basis of above results, (1) a C-terminal tail must be
present and (2) the wild-type ETB, not the wild-type ETA
receptor is required for ET-1 stimulation of NaDC-1 activity.
Table 1 | Arterial blood gases and plasma chemistries
EndothelinB
+/+ mice EndothelinB
/ mice
Control, n=16–18 Acid, n=16–18 Control, n=16–18 Acid, n=16–18
pH 7.23±0.01 7.09±0.02* 7.25±0.01 7.11±0.02*
pCO2, mm Hg 52±1 55±2 51±2 56±3
[HCO3
], mM 21.7±0.3 16.6±0.5* 22.2±0.4 17.7±0.7*
D[HCO3
], mM 5.06±0.60 4.43±0.93
Na+, mmol/l 144±1 148±1* 143±1 150±1*
K+, mmol/l 3.8±0.1 4.3±0.2 4.1±0.1 4.5±0.1
Cl, mmol/l 116±1 123±1* 115±1 124±1*
*Po0.05 versus respective control group.
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Figure 7 | Stimulation of opossum kidney cell line Na-
dependent dicarboxylate cotransporter-1 activity by acid
feeding is dependent on the (endothelin B) ETB receptor.
ETB
þ /þ and ETB
/ mice were provided with plain drinking water
or drinking water containing 0.3mol/l NH4Cl ad lib 7 days.
Kidney cortex was harvested, brush border membrane vesicles
prepared, and Na-dependent [14C]-citrate uptake measured as
described in the Methods section. All assays were carried out in
triplicate and meaned to obtain a transport rate for this study.
*Po0.05 versus mice drinking plain water. n¼ 6 for all groups.
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To identify the region of the ETB C-terminal tail involved in
ET-1 stimulation of oNaDC-1 activity, a series of C-terminal
truncations were used. Figure 9a shows a schematic diagram
of these truncations starting with the last three residues of the
last TM domain (YLV). The specific truncations were made
to (1) remove the most C-terminal five serine residues (D11),
(2) remove Tyr430 (D23), (3) remove three additional serine
residues (D37), (4) remove four cysteine residues, three of
which are the known palmitoylation sites required for
coupling with the G-protein signaling pathways (D43), and
(5) remove the serine and cysteine residues closest to the
seventh TM domain (D47).
As shown in Figure 9b, removing the terminal 11 amino
acids (D11) does not significantly decrease the magnitude of
ET-1 stimulation of oNaDC-1 activity. Removing the last 23
residues (D23) reduces the ET-1 effect by 50%, although the
magnitude of ET-1 stimulation is still statistically significant
and not different from the stimulation that occurs in the
presence of the wild-type receptor. Removing another 14
resides (D37) has no additional effect on ET-1 stimulation of
oNaDC-1 activity. However, removing the terminal 43 or 47
amino acid residues (D43 or D47) prevents ET-1 stimulation
of oNaDC-1 activity. These latter truncations are consistent
with the studies presented in Figure 8, showing that removal
of the C-terminal tail (the D43 construct) prevents ET-1
stimulation of oNaDC-1 activity.
The ETB C-terminal tail has relatively few identifiable
consensus sequences that might suggest the specific key
amino acid resides involved in ET-1 stimulation of oNaDC-1
activity. Between the D37 and D43 truncation sites, wherein
ET-1 stimulation was blocked entirely, there are three
palmitoylation sites, and between the D11 and D23 trunca-
tion sites, wherein 50% of the stimulatory effect was lost, is a
SH2 binding domain. This latter domain contains a tyrosine
residue, amino acid 430, one of only two tyrosine residues in
the C-terminal tail, the other one being four residues from
the C-terminal end of the protein and having no impact on
ET-1 stimulation of oNaDC-1 activity when removed (D11).
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Figure 8 | Endothelin B (ETB) C-terminal tail required for ET-1
stimulation of opossum kidney cell line Na-dependent
dicarboxylate cotransporter-1 (oNaDC-1) activity. Cells were
transfected with oNaDC-1 and the wild-type or chimeric receptor
as indicated on the x-axis and [14C]-citrate uptake was measured.
ETA: wild-type ETA receptor; ETB: wild-type ETB receptor; ETB no
tail: ETB receptor without a C-terminal tail; ETB TM/ETA tail:
chimeric receptor including the ETB transmembrane (TM) domains
and ETA C-terminal tail; ETA TM/ETB tail: chimeric receptor
including the ETA transmembrane domains and ETB C-terminal
tail. Statistical results from the one-way analysis of variance are
included in the figure. *Po0.05 for the ET-1:vehicle ratio being
statistically greater than 100. n¼ 9 for ETA and ETB no tail studies;
n¼ 18 for ETA TM/ETB tail and ETB TM/ETA tail studies; n¼ 23 for
wild-type ETB studies. Abbreviation: NS, not significant.
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hETB Δ37
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Figure 9 | Endothelin B (ETB) C-terminal truncations alter ET-1
regulation of opossum kidney cell line Na-dependent
dicarboxylate cotransporter-1 activity. (a) The wild-type (WT)
human ETB (hETB) C-terminal sequence and five truncations are
shown. The underlined and italized residues (YLV) represent the
end of the last transmembrane domain. The D43 truncation is the
construct used for the studies in Figure 8 labeled ETB no tail.
(b) Cells were transfected with oNaDC-1 and the WT or truncated
receptor as indicated on the x-axis and [14C]-citrate uptake was
measured. *Po0.05 versus vehicle; #P¼ 0.051 versus vehicle.
n¼ 27 for ETB; n¼ 9 for D11, n¼ 18 for D23, n¼ 21 for D37 and
D43, and n¼ 23 for D47.
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To determine if Tyr430 has a role in ET-1 stimulation of
oNaDC-1 activity, cells were transfected with oNaDC-1 and a
mutant ETB receptor in which Tyr
430 was replaced with
phenylalanine (ETB
Y430F). As shown in Figure 10, removal of
Tyr430 has no effect on ET-1 stimulation of [14C]-citrate
uptake.
DISCUSSION
In vivo proximal tubule apical membrane NaDC-1 activity
increases in response to a dietary acid load and in vitro in
response to media acidification.11,13–15,27 This Na-dependent
citrate transporter mediates most of citrate reabsorption in
the nephron, and thus, transporter activity is a primary
determinant of citrate excretion.10 These studies establish
that a functional ETB receptor is required for acid stimulation
of NaDC-1 activity both in vitro (OKP cells) and in vivo
(comparing ETB
þ /þ with ETB
/ mice).
Despite a dependence on the ETB receptor for acid
stimulation of NaDC-1 activity, as shown in Table 1, plasma
[HCO3] decreases to the same extend in ETB
þ /þ to ETB
/
mice. In metabolic acidosis citrate excretion is reduced to
minimize base loss in the face of base shortage. However,
comparing the amount of bicarbonate generated from the
metabolism of the retained citrate with the amount of
bicarbonate generated by ammonium excretion, citrate
metabolism accounts foro10% of the bicarbonate generated
by these proximal tubule processes, and thus, is not a major
determinant of systemic acid-base balance.
The reason proximal tubule citrate handling is of
physiological and clinical interest in metabolic acidosis is
that the hypocitraturia consequent of minimizing base
excretion increases the risk for kidney stones. Of the urinary
anions, citrate has the highest affinity for calcium. The
calcium citrate complex is soluble, making the availability of
citrate in the urine a key factor in determining the risk for
kidney stone formation.28 In response to an acid load or in
conditions that decrease intracellular pH, such as chronic
potassium deficiency, citrate reabsorption and metabolism
increase, resulting in less citrate in the urine and an increased
risk for kidney stone formation.3,4,27,28
To elucidate the acid-activated pathway that mediates
stimulation of NaDC-1 activity and confirm that the findings
are relevant to the in vivo setting, we use both in vitro (cell
culture—media acidification) and in vivo (whole animal—
acid feeding) models of an acid load. Even though the time
course of these studies are different (cell culture studies
conducted after hours of exposure to acid media and whole-
animal studies conducted after days of acid feeding), several
pieces of evidence suggest that the effects are mediated by
the same acid-activated pathway: (1) the acid stimulatory
effect on NHE3 and NaDC-1 activities in cell culture is absent
in the presence of the specific ETB blocker, BQ788 (in vitro
model) and in BBMV harvested from ETB
/ mice (in vivo
model) (this paper and by Laghmani et al.23 (2) The acid
stimulatory effect on NHE3 and NaDC-1 activities in cell
culture is absent after the transfection of a dominant-negative
or siRNA Pyk2 construct (in vitro model) and in BBMV
harvested from Pyk2/ mice (in vivo model).29–31 (3) Media
acidification (in vitro model) leads to activation of c-Src and
acid feeding (in vivo model) increases renal cortical c-Src
kinase activity.32,33 (4) Acid-induced phosphorylation of ATP
citrate lyase is not blocked in the presence of the specific ETB
blocker, BQ788 (in vitro model), and is present in renal
cortex harvested from ETB
/ mice (in vivo model) (unpub-
lished observations).
The OKP cell was used as the in vitro model, because in
these cells media acidification has the same effect on other
proximal tubule transporters as acid feeding does in the
intact proximal tubule.34–36 The OKP NaDC-1 cotransporter
was cloned and shown to have biochemical characteristics
consistent with rat, rabbit, and human NaDC-1.19 These
studies show that both media acidification and exposure to
ET-1 in the presence of the ETB receptor stimulate oNaDC-1
activity in both a dose- and time-dependent manner, with
maximal uptake at a media pH of 6.8 that begins within 2 h
of exposure to the acid media, and in the presence of
108mol/l ET-1 that begins within 15min exposure to the
ET-1 (Figures 2 and 3). The likely reason for the difference in
the time required for stimulation of NaDC-1 activity by acid
(2 h) and ET-1 (15min) is that acid stimulation of NaDC-1
activity requires the acid media to stimulate ET-1 synthesis,
which then must be secreted and function in an autocrine
manner to stimulate NaDC-1 activity through the ETB
receptor.37
For a similar reason, a possible explanation for the ET-1
effect being gone at 8 h but the acid effect remaining at 24 h is
that the ET-1 added to the media has been degraded by 8 h,
whereas in the acid studies, with the media still being
acidic, the stimulation for ET-1 synthesis continues for 24 h
(Figures 2 and 3).
In vitro (comparing media acidification-induced citrate
uptake in the absence and presence of a specific ETB receptor
blocker) and in vivo (comparing acid feeding-induced citrate
uptake in BBMVs made from ETB
þ /þ and ETB
/ mice), acid
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Figure 10 | Endothelin B (ETB) C-terminal Tyr
430 is not involved
in ET-1 stimulation of opossum kidney cell line Na-dependent
dicarboxylate cotransporter-1 (oNaDC-1) activity. Cells were
cotransfected with oNaDC-1 and either the wild-type ETB receptor
or ETB
Y430F mutant receptor, and [14C]-citrate uptake was
measured. *Po0.01 versus vehicle. n¼ 8 for both groups.
Kidney International (2010) 78, 895–904 901
L Liu et al.: Acid regulation of NaDC-1 o r ig ina l a r t i c l e
stimulation of NaDC-1 activity requires a functional ETB
receptor. We have previously shown in both OKP cells and
kidney cortex that media acidification or acid feeding,
respectively, increases ET-1 synthesis.37,38 Taken together,
these studies support the hypothesis that an acid load
increases ET-1 synthesis, which then, in an autocrine or
paracrine manner, signals through the ETB receptor to
mediate stimulation of NaDC-1 activity.37
The requirement for a functional ETB receptor for acid
and ET-1 stimulation of NaDC-1 activity parallels the
requirement for a functional ETB receptor for acid and
ET-1 stimulation of NHE3 activity.23,39,40 Increases in NHE3
activity enhance acid excretion, whereas increases in NaDC-1
activity decrease base loss. Thus, acid-induced adaptations in
both NHE3 and NaDC-1 activities maximize the ability of the
kidney to increase net acid excretion and minimize an effect
on systemic acid–base balance.
In addition, identical is the observation that in the
presence of the ETA receptor, ET-1 fails to stimulate either
NaDC-1 or NHE3 activity, and in fact, leads to an inhibition
of transporter activity (this study)20,40. Although, additional
studies from our laboratory showed that the ETA C-terminal
tail is necessary and sufficient for ET-1-induced inhibition of
NHE3 activity, these studies show that the wild-type ETA
receptor (TM and C-terminal domains), not just the
C-terminal tail is required for inhibition of NaDC-1.40 Taken
together, these observations raise the possibility that
exogenous ETA receptor expression sequesters a protein
required for ETB-mediated stimulation of oNaDC-1 and
NHE3 activities and that the effective-binding site of this
protein to the ETA receptor may be different for oNaDC-1
and NHE3 regulation.
These studies also show that baseline (vehicle) NaDC-1
activity decreases in OKP cells transfected with the ETA
receptor. This observation is different than the effect on
NHE3 activity, in which baseline activity is increased.40 The
reason for this difference is presently unknown.
Further studies were conducted to determine the region
within the ETB receptor that mediates ET-1 stimulation of
NaDC-1 activity. Within the ETB C-terminal tail 50% of the
ET-1 effect is mediated by amino acid residues between
residues 11 and 23 (counting backwards from the end of the
C-terminus), although NaDC-1 activity is still significantly
increased by ET-1 in the D23 construct and not different than
in the presence of the wild-type ETB receptor. There is a
potential SH2-binding domain between residues 11 and 23
that contains a tyrosine residue at aa430. Although removal
of these 12 amino acids reduces the ET-1 effect by 50%,
replacing Tyr430 with phenylalanine has no effect on ET-1
stimulation of NaDC-1 activity, showing that Tyr430 is not
required for ET-1 stimulation of NaDC-1 activity.
ET-1 stimulation is, however, totally abolished by removal
of the amino acids between residues 37 and 43. The D43 and
D47 constructs remove essentially all of the C-terminal tail.
Our laboratory40 and Okamoto et al.41 have published
receptor binding studies showing that in cells transfected
with wild-type, chimeric, or mutated ETB receptors, ET-1
binding is not different between the wild-type and various
constructs. Although the lack of a stimulatory effect in the
presence of the transfected, mutant receptor infers that these
receptors are less active, it is also possible that the mutant
receptors are dominant negative to the endogenous wild-type
receptor. It is unlikely that such an effect would be
attributable to limited agonist, but could be because of the
cellular constituents that are required for receptor activity
and are being sequestered by the transfected receptors.
However, the conclusions of this study are unaffected
whether the mutations create an inactive or a dominant-
negative receptor, the key conclusion being that the receptor
is no longer active and, thus, the physiological effect lost.
Okamoto et al.41 showed that the palmitoylation sites
(cysteine resides 402, 403, and 405) have a critical role in the
coupling with G-proteins, regardless of the G-protein subtype,
but do not have a role in receptor localization on the cell
surface, ET-1 or ET-3 binding, or receptor internalization when
bound to ligand. Single and combined mutations of the three
cysteine residues showed that at least one of the three sites is
required for G-protein signaling. In addition, C-terminal
truncation removing C403 and C405, but leaving C402 showed
that, in addition, to one palmitoylation site, activation of Gi
(cAMP), but not with Gq (Ca
þ 2-dependent) pathways, also
requires the C-terminal tail.
In these studies, removal of the terminal 23 or 37 residues
(leaving all three palmitoylation sites intact) reduces the ET-1
effect, although the magnitude of the remaining stimulation
is not statistically different than that seen with the wild-type
receptor (Figure 9b). However, removing the three palmi-
toylation sites (D43 or D47 constructs) abolishes the ET-1
stimulatory effect, which taken together with the studies by
Okamoto et al., suggests that ET-1 stimulation of NaDC-1
activity is mediated by G-protein-coupled signaling. As we
have shown that ET 1 stimulation of NaDC-1 activity does
not involve cAMP, but requires Caþ 2 for the full effect, these
studies suggest that the ET-1 effect is mediated by a Gq
pathway (unpublished results).
Thus, acid stimulation of the proximal tubule apical
membrane transporters NHE3 and NaDC-1 requires a
functional ETB receptor in OKP cells and in vivo, and can
be mimicked in OKP cells by exposure to ET-1. Similarly, the
ET-1 effect leads to inhibition of both transport activities
when ETA receptors are exogenously expressed. However,
necessary and sufficient regions of the ETB receptor differ for
stimulation of the two transporters. Although the ETB C-
terminal tail is necessary for maximal stimulation of both, it
is only sufficient for ET-1 stimulation of NaDC-1 activity; the
KXXXVPKXXXV sequence within the second intracellular
loop is also required for stimulation of NHE3 activity.40
Recent preliminary studies have identified another difference
in the pathway that mediates ET-1 stimulation of NHE3 and
oNaDC-1. ET-1 stimulation of NHE3, but not of oNaDC-1
activity is a Rho kinase- and stress fiber-dependent
process.31,42 Thus, it is possible that the ETB receptor second
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intracellular loop regulates signaling involved with Rho
kinase activation and stress fiber formation, whereas the
C-terminal tail is involved in another aspect of transporter
stimulation that is common to both transporters, and
sufficient for stimulation of NaDC-1 activity.
MATERIALS AND METHODS
Materials and supplies
All chemicals were obtained from Sigma Chemical (St Louis, MO,
USA) except as follows: penicillin from Whittaker MA Bioproducts
(Walkersville, MD, USA), culture media from GIBCO BRL (Grand
Island, NY, USA); ET-1 from Peptides International (Louisville, KY,
USA); [14C]-citrate from Amersham (Arlington Heights, IL, USA).
Cell culture
OKP cells were passaged in high-glucose (450mg/dl) Dulbecco’s
modified Eagle’s media supplemented with 10% fetal bovine serum,
penicillin (100U/ml), and streptomycin (100 mg/ml). For experi-
mentation, confluent cells were rendered quiescent by removal of
serum, and media was changed to low glucose (100mg/dl)
Dulbecco’s modified Eagle’s media 24 h.
NaDC-1 activity ([14C]-citrate uptake)
Cells were plated in six-well culture plates, grown to 60–70%
confluence, and transfected with 1 mg DNA using the pME18sf
empty plasmid or the plasmid containing the human wild-type ETA,
wild-type ETB, a chimeric, or a mutant receptor driven by the SRa
promoter for over expressing the receptors and the pEGFP-C3
empty plasmid or plasmid containing oNaDC-1 driven by a SV40
promoter for over expressing oNaDC-1. All transfections were
carried out using the Lipofectamin Plus kit (Invitrogen, Carlsbad,
CA, USA) 5 h.43,44 Serum (10% fetal bovine serum) was then
added to the wells 19 h, after which the cells were 95–100%
confluent. The cells were rendered quiescent 24 h by the removal
of the serum, and then exposed to one of the following experimental
protocols. Cells were exposed to the same media at pH 7.4, 7.3, 7.2,
7.0, or 6.8, as noted for each experiment, or in the presence or
absence of ET-1 or vehicle (0.0002% acetic acid). Media was
acidified by the addition of HCl and then incubated in the tissue
culture incubator for several hours before being added to the cells.
We have shown that this approach leads to a consistent media pH.
[14C]-citrate uptake was measured at pH 7.4 5min in the
presence (136mM) or absence of NaCl (NaCl replaced with 136mM
choline Cl) using a solution containing, in addition to either NaCl or
choline Cl, 1.2mM CaCl2, 1mM MgSO4, 3mM KCl, 25mM 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), 1.39mM
citric acid, and 0.5mCi/ml [14C]-citrate. The uptake reaction was
stopped, and the remaining extracellular [14C]-citrate removed by
washing the cells three times with ice-cold 0.1M MgCl2 solution.
After the last wash, the cells were lysed in 300ml of 0.1N NaOH and
scrapped with a rubber policeman. A 10ml aliquot was used to
measure protein content by Bradford assay (Bio-Rad Laboratories,
Hercules, CA, USA); the remaining 290ml were put into 5ml of
scintillation fluid and [14C]-citrate counted with a scintillation
counter (UT Southwestern: Beckman LS3801; Yale: Packard Tri-Carb
2900TR). Uptakes are reported as pmoles citrate/mg protein/5min.
Location of GFP-oNaDC-1 expression
OKP cells were grown on polyethylene terephtalate track-etched
membranes and transiently transfected with GFP-oNaDC-1 and the
ETB receptor as described above. After transfection, cells were
rendered quiescent by removing the serum 24 h. For experimenta-
tion, cells were exposed to vehicle or 108M ET-1 or control (pH
7.4) or acidic media (pH 6.8) 35min or 6 h, respectively. Cells
were then washed with phosphate buffered-saline and inserts
mounted on glass slides sealed with coverslips and nail polish.
Confocal images were obtained using a laser scanning fluorescent
microscope (LSM410; Zeiss, Thornwood, NY, USA).
Experimental animals
In vivo experiments were carried out in 4–5-month-old age- and sex-
matched wild-type mice and mice in which the ETB receptor was
genetically disrupted by homologous recombination and rescued
from aganglionic megacolon by expression of a dopamine
b-hygroxylase promoter/ETB receptor transgene.
22,24 Confirmation
that the ETB receptor was not expressed in the kidney in the rescued
mice was obtained by polymerase chain reaction using a forward
primer from exon 1 and a reverse primer from exon 3. As a control
for loading, cyclophilin abundance was assayed and shown to be the
same in wild-type and knock-out tissue.
Metabolic acidosis was induced by providing drinking water
that contained 0.3M NH4Cl 7 days; control mice received
plain drinking water. After anesthetizing the mice with isoflurane
by inhalation (Baxter, Deerfield, IL, USA), the kidneys were rapidly
harvested and keep in 1 phosphate-buffered saline on ice until
the cortex was removed. Arterial blood was collected in anesthesized
mice before harvesting the kidneys and blood gases measured
using a Heska i-STAT portable clinical analyzer (Loveland, CO,
USA).
BBMV isolation and measurement of NaDC-1 transport activity
NaDC-1 activity was assayed as [14C]-citrate uptake in BBMV.
Briefly, dissected kidney cortex from six kidneys was immersed in
ice-cold buffer containing 300mM mannitol, 5mM ethylene glycol
tetraacetic acid, 18mM HEPES, and 0.1mM phenylmethylsulfonyl
fluoride titrated to pH 7.5 with Tris, and homogenized 5 s 15
times with a Polytron homogenizer (Brinkmann Instruments,
Westburg, NY, USA) followed by homogenization by 10 stokes in
a Teflon-glass homogenizer at 41C. BBMV were isolated using the
Mg-ethylene glycol tetraacetic acid aggregation method.4 The final
BBMV fraction was loaded with intravesicular buffer (in mM) (200
Mannitol, 50 KCl, and 16 HEPES, titrated to pH 7.5 with Tris). A
total of 45 ml extracellular buffer (in mM) (100 NaCl/100 Choline Cl,
50 KCl, and 16 HEPES, titrated to pH 7.5 with Tris) containing
0.1mM [14C]-citrate was added to 15 ml of BBMV (100–110mg
protein) at room temterature. After 5 s the reaction was stopped by
addition of ice-cold stop solution (in mM) (135 NaCl, 10 Na2
succinate, and 16 HEPES, titrated to pH 7.5 with Tris), the sample
filtered through a 0.65mm filter (Millipore Corp., Bedford,
Massachusetts, USA), the filter put into 5ml of scintillation fluid,
and [14C]-citrate counted using a Beckman scintillation counter
(Packard Tri-Carb 2900TR, Downers Grove, IL, USA). [14C]-citrate
uptake was carried out in triplicate and meaned for a single value for
the sample. Uptake is reported as pmoles citrate/mg protein/5 s.
Statistics
All multigroup statistical analyses were carried out using an analysis
of variance and statistical significance determined by carrying out
the appropriate t-test. Differences between means were considered
significant at Po0.05.
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